Pharmaceutical 4781 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

States prosecute Johnson & Johnson alleging ‘deceptive practices’ related to transvaginal mesh


Besides the 35,000 personal injury lawsuits that Johnson and Johnson faces related to its transvaginal mesh (TVM), the company is also facing suits by both the states of Washington and California. According to Law360, the states’ attorneys general filed complaints against the company and its subsidiary Ethicon Inc. alleging false advertising and deceptive marketing related to the devices. The complaints claim J&J knowingly concealed the risks associated with its TVM product and misrepresented the severity and frequency of common complications. The complaints also claim violations of the states’ unfair competition and consumer protection laws. Law360 reported that “Both states are seeking injunctive relief and ... Read More

Man sues Xarelto makers over bleeding side effects


Austin Foster, of Illinois, is suing the makers of the popular blood thinner Xarelto, claiming the medication caused him to bleed internally, putting his life at serious risk. Foster’s complaint was filed in the U.S. District Court for the Eastern District of Louisiana and names Johnson & Johnson, its subsidiary Janssen Pharmaceuticals, Bayer Healthcare, and their related companies. The lawsuit alleges the companies violated Consumer Protection Laws by not accurately researching the medication to identify potential risks and failing to warn the of bleeding risks and the need for dose adjustments. Xarelto was approved by the Food and Drug Administration ... Read More

Johnson & Johnson Requesting a Freeze on Upcoming Hip Implant Bellwether Trials after $5 Million Verdict


Last March, Johnson & Johnson and its subsidiary, DePuy Orthopedics, took a hit when the jury of the bellwether trial in hip implant litigation sided with the five plaintiffs, awarding them with a jaw-dropping total of $497.6 million. The lawsuits were regarding injuries resulting from the DePuy Pinnacle metal-on-metal hip implant devices for failure-to-warn and design defect claims, as decided by a federal jury in Dallas, Texas. The first trial began in January and took eight weeks to conclude. The jury deliberated for five days before returning with the verdict. Beasley Allen Principal Navan Ward, Jr. served as a member of the Plaintiffs’ Steering Committee (PSC) working hard to ... Read More

Dr. warns of cancer risk with breast implants


Dr. Mark Clemens, a pastic and reconstructive surgeon at MD Anderson, is warning women with breast implants that they are at risk for a type of cancer called Anaplastic Large Cell Lymphoma (ALCL). The risk is rare, and the prognosis is generally good, but the diagnosis can be devastating. It was for Raylene Hollrah. The breast cancer survivor didn’t expect to hear the diagnosis again after she successfully went through treatment for her disease and then reconstructive surgery, during which she got breast implants. “I got the news I was diagnosed with Anaplastic Large Cell Lymphoma and I really knew ... Read More

Diabetes drug Januvia with statins may increase risk of severe muscle damage

januvia - sitagliptin

Cholesterol-lowering statins are widely used but are also not tolerated by many people because the side effects can be unbearable. The most common adverse events include muscle aches and pain and increases in blood sugar that can lead to type 2 diabetes. Statins can also lead to a life-threatening muscle damage called rhabdomyolysis. This condition can cause muscle pain, liver damage, kidney failure and death. Rhabdomyolysis is a rare statin side effect, but a case study published in the International Journal of General Medicine has found that the type 2 diabetes medication Januvia taken with a statin may increase the ... Read More

More women sue Bayer over alleged Essure birth control injuries


Three women are suing Bayer Healthcare claiming the company’s Essure permanent birth control device caused them persistent abdominal and pelvic pain and “unnatural menstrual cycles.” Essure was approved in 2002 and remains the only non-surgical, permanent birth control method on the market. The method involves two nickel alloy coils that are inserted into the fallopian tubes where they are designed to prevent pregnancy by blocking the sperm’s access to the egg. The devices have been associated with tens of thousands of complaints including allergic reactions, autoimmune reactions, abdominal pain and unusual bleeding. The coils can also migrate and perforate the ... Read More

Blood transfer device used on infants recalled


A blood transfer device used to collect blood samples from infants, including premature babies, is being recalled because of a defect that could result in serious adverse health consequences, including death. The recall involves the Hummi Micro-Draw Blood Transfer Device, made by Hummingbird Med Devices Inc. The Y-shaped connector and the yellow tube may disconnect from each other prior to or during use. This could lead to blood or fluid leakage. Affected devices have the lot numbers 15180, 15286, 15287, 15300, and 15305. The blood transfer systems were manufactured from June 29, 2015, to Dec. 2, 2015, and distributed from Oct. ... Read More

Xarelto sales expected to remain strong despite bleeding risks


Johnson & Johnson’s Janssen Pharmaceuticals and Bayer’s Xarelto reigns as the king of blood thinners in sales in the United States and Europe. In the U.S., Bristol-Myers Squibb and Pfizer’s Eliquis is gaining on Xarelto, but analysts say Xarelto should remain tops in the UK until 2022, at which point the medication could be bringing in an estimated €2.72 billion in sales – the equivalent to $3.03 billion. Xarelto and Eliquis are in a new class of blood thinners designed as a more convenient alternative to warfarin because they have far fewer food and drug interactions. They are used to ... Read More

Supermodel believes breast implants impacted her cancer diagnosis


When supermodel Janice Dickinson, 61, was diagnosed with stage 1 breast cancer and learned that her breast implants could make detecting abnormalities in breast tissue more difficult, she insisted on having hers removed. “Take them out! Take them out, cut them out! Just take them out now!” Dickinson said she told her doctor. Asked if she had known the risk, “I would have never gotten breast implants in the first place,” she said. Dickinson underwent surgery to have her tumor and breast implants removed. She did not need a mastectomy but will have to undergo radiation therapy. She says she ... Read More

Surgery to Retrieve Migrating IVC Filter Leaves Woman with 11-Inch Scar

IVC filter

A recipient of Cook Medical’s Gunther Tulip, an inferior vena cava (IVC) filter, is left with an 11-inch long, 1/4-inch wide abdominal scar where she had surgery to retrieve the filter that was migrating toward her spine. IVC filters are small cage-like devices that are implanted in the vena cava, the body’s largest vein, which runs along the spine. They are designed to catch blood clots before they reach the heart, lungs and/or brain. But many IVC filter models such as Cook Medical’s Gunther Tulip and Celect models, as well as C.R. Bard’s Recovery, G2 and G2 Express, have been linked to life-threatening complications ... Read More